omniture
ILIAS BIOLOGICS INC

Latest News

ILIAS Biologics Inc. demonstrated the therapeutic effect of anti-inflammatory exosomes for ischemia-reperfusion-induced acute kidney injury

DAEJEON, South Korea, June 28, 2021 /PRNewswire/ -- Anti-inflammatory exosomes could have a place i...

2021-06-28 20:00 1447

ILIAS Biologics announces the 2nd POC study, showing anti-inflammatory effects of ILB202 on preterm birth

DAEJEON, South Korea, Feb. 1, 2021 /PRNewswire/ -- ILIAS Biologics, Inc. announced that its latest ...

2021-02-02 02:00 1490

ILIAS Biologics Closes $20.6 Million Series B Financing

DAEJEON, South Korea, Sept. 28, 2020 /PRNewswire/ -- ILIAS Biologics Inc. (the "Company" or "ILIAS"...

2020-09-28 19:00 1712

ILIAS Biologics Granted Key Patent for Exosome-based Drug Delivery System in the United States

DAEJEON, South Korea, July 7, 2020 /PRNewswire/ -- ILIAS Biologics Inc. (the "Company" or "ILIAS"),...

2020-07-08 01:00 1344